NEW YORK (GenomeWeb News) – Bruker Daltonik and Carl Zeiss MicroImaging have integrated their respective molecular imaging and virtual imaging technologies for use in molecular histology research, Bruker said today.
The integration of Bruker's MALDI Molecular Imager and the Carl Zeiss' Virtual Slide Scanner will enable researchers to directly overlay microscopic images with molecular and spectral information in one software visualization tool, Bruker said. Previously, the company said, interpreting MALDI imaging data in pathology research required "repeated switching" between the MALDI molecular and microscopic images.
Sören-Oliver Deininger, a product specialist at Bruker Daltonics, said in a statement that the integration will "significantly accelerate clinical pathology research, particularly in oncology, where the untargeted molecular information is expected to reveal additional subtle changes in tissue that cannot be distinguished by traditional histology methods today."